Skip to main content
Equibles

Legal & General Group Plc

Position in TLRY — Tilray Brands, Inc.

CIK 764068 London, X0
Back to TLRY Full portfolio

Position in TLRY

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$381,294
-$94,379 QoQ
Shares Held
84,921
+15.5% QoQ
Ownership
0.062%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#28
of 235 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in TLRY Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

Legal & General Group Plc holds $776,969,626 across 46 Drug Manufacturers - Specialty & Generic names. TLRY ranks #32 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ZTS
Zoetis Inc.
 3,567,388 $256,352,500
2 TEVA
Teva Pharmaceutical Industries Ltd
 3,916,666 $132,696,643
3 UTHR
UNITED THERAPEUTICS Corp
 207,093 $112,209,199
4 VTRS
Viatris Inc
 4,069,647 $64,625,993
5 NBIX
Neurocrine Biosciences Inc
 314,451 $52,997,570
6 ALKS
Alkermes plc.
 393,524 $20,620,657
7 ELAN
Elanco Animal Health Inc
 711,233 $17,503,443
8 XERS
Xeris Biopharma Holdings, Inc.
 2,012,792 $15,941,311

All Filings in TLRY

Export CSV
25 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $381,294 84,921
2026-03-31 $475,673 73,520
2025-12-31 $716,828 79,383
2025-09-30 $1,373,364 793,853
2025-06-30 $310,007 756,116
2025-03-31 $499,035 756,116
2024-12-31 $956,185 718,937
2024-09-30 $1,118,161 635,319
2024-06-30 $1,185,048 713,885
2023-12-31 $1,272,281 553,166
2023-09-30 $1,322,066 553,166
2023-06-30 $738,511 473,405
2023-03-31 $1,197,714 473,405
2022-12-31 $1,278,148 475,148
2022-09-30 $1,071,119 389,498
2022-06-30 $1,173,700 376,186
2022-03-31 $2,744,161 353,174
2021-12-31 $2,476,240 352,239
2021-09-30 $3,621,006 320,727
2021-06-30 $927,395 51,294
2021-03-31 $328,539 14,454
2020-12-31 $6,195 750
2020-09-30 $20,200 4,165
2020-06-30 $5,688 800
2020-03-31 $5,504 800